Your Position: Home > Transgenesis > PhiC31 System

PhiC31 integrase-mediated transgenesis systems

PhiC31 integrase-mediated transgenesis systems are based on the site-specific bacteriophage PhiC31 integrase which mediates sequence-directed, irreversible and highly efficient integration between a bacterial attachment site (attB) and a phage attachment site (attP). Injecting plasmid containing attB site into attP-containing docking site strain(s) with PhiC31 integrase activity makes the resultant stable transformants containing your gene-of-interest between attL and attR sites (irreversible).

We use M{vas-int.Dm}ZH-2A (RFP+, GFP+ phenotype) as the genomic PhiC31 source if the attP site stock does not contain it. If the screening marker is fluorescence-related, we may use the genomic P{nos-phiC31\int.NLS}X source (y+, non-fluorescence), please let us know if this is the case.

For vermilion+ markers, e.g. for creating stable attP-gRNA lines, you may actually choose the v+ based attP site on autosomal chromosome lines from these below lists. We may setup the crosses to the y-v- line and screen for v+. You may get the same v+ G2 transformants as using the v- based attP lines. If v+ transformant  on X chromosome, please choose X chromosomal v- background attP line, such as BDSC#34769. This is just regular Plan H or Plan I with extra vermilion+ screening. You may also ask us to keep the resulting gRNA lines and have us cross to the proper Cas9 stock and inject their F1s (additional Plan RG/RH/RI) later.

P{CaryP}
Two attP landing sites were created by the Calos group. These two sites were initially created by the traditional P-element system with yellow marker.

Additional attP landing sites were created by the Perrimon group, and were tested for position effects by luciferase expression on various tissues.

And a strain with P{CaryP}attP at Y chromosome was created by Bellen lab.

See below papers for more info.

PhiC31-RMCE
In June, 2006, the Wu lab published a method that targets constructs to predetermined genomic sites using the PhiC31 integrase system in conjunction with Recombinase Mediated Cassette Exchange (RMCE).

See below paper for more info.

P[acman]
P[acman] system makes use of the combined tools of a conditional amplifiable technique for typical P1 and BAC construct, recombineering, and PhiC31-mediated trangenesis. It has the advantage of delivering large DNA fragments into specific genomic locations with attP site, which were generated by the Bellen lab and markered by yellow. Here we are incorporating the P[acman] system with the work from the Basler group which used genomic PhiC31 integrase source instead of co-injecting the PhiC31 mRNA.

In addition, two genomic BAC libraries ("CHORI-321", 83 kb and "CHORI-322" 21 kb average clone size) have been generated based on P[acman] vector.

Please see below paper and visit the Bellen labCHORI BACPAC Resources for more info:
http://flypush.imgen.bcm.tmc.edu/lab/index.html

https://bacpacresources.org/library.php?id=444

https://bacpacresources.org/library.php?id=445

FlyC31
In FlyC31 system, a library of landing platforms conaining attP site throughout the Drosophila genome were created by the Basler and Karch groups, which are ready for the transgenesis of the construct with attB site. These landing platforms were deliberately designed to be manipulated in vivo by Cre/loxP system after transgenesis to get rid of  of the non-necessary sequences and only keep your DNA fragment flanking with one loxP and one attL site (We do not provide this Cre/loxP service).

In order to use Fluorescence screening marker, Cre/loxP excision were performed to get rid of 3xP3-RFP sequence at these attP site, NF lines.

Please see below paper, the listed stocks and visit the FlyC31 website for more info:

http://www.flyc31.org/

MiMIC
MiMIC is a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes. MiMIC system was developed by the collaboration among the laboratories of Hugo Bellen (Baylor College of Medicine), Roger Hoskins (Lawrence Berkeley National Laboratory) and Allan Spradling (Carnegie Institution of Washington).
Please see below paper and visit the Bellen lab MiMIC page for more info:

http://flypush.imgen.bcm.tmc.edu/pscreen/technique.html

The listed strains do not contain genomic PhiC31 integrase source except indicated

Except indicated, we keep and use the attP stains without PhiC31 source for stable long-term passage. e.g. the Fly31 attP strains do not contian M{vas-int.Dm}ZH-2A. The injected G0 flies are the F1 of attP stock crossed with PhiC31 source strain.

The PhiC31 system and the Gateway System
One of the "Gateway-PhiC31 system", for example, can be found here. Please note the attP1, attP2, attB1, attB2, etc, at the original Murphys Gateway are of different concepts.


Reference
Groth A, Fish M, Nusse R, Calos MP (2004) Construction of transgenic Drosophila by using the site-specific integrase from phage PhiC31. Genetics 166: 1775

Markstein M, Pitsouli C, Villalta C, Celniker SE, Perrimon N (2008) Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nature Genetics 40: 476
Szabad J, Bellen HJ, Venken KJT (2012) An Assay to Detect In Vivo Y Chromosome Loss in Drosophila Wing Disc Cells. G3 (Bethesda) 2(9): 1095
Bateman JR, Lee AM, Wu C-t (2006) Site-specific transformation of Drosophila via PhiC31 integrase-mediated cassette exchange. Genetics 173: 769
Sun FF, Johnson JE, Zeidler MP, Bateman JR (2012) Simplified Insertion of Transgenes Onto Balancer Chromosomes via Recombinase-Mediated Cassette Exchange. G3 2: 551
Venken KJT, He Y, Hoskins RA, Bellen HJ (2006) PhiC31: a BAC transgenic platform for targeted insertion of large DNA fragments in Drosophila melanogaster. Science 314: 1747
Bischof J, Maeda RK, Hediger M, Karch F, Basler K (2007) An optimized transgenesis system for Drosophila using germ-line-specific PhiC31 integrases. Proc Natl Acad Sci USA 104: 3312
Venken KJT, Schulze KL, Haelterman NA, Pan H, He Y, Evans-Holm M, Carlson JW, Levis RW, Spradling AC, Hoskins RA, Bellen HJ (2011) MiMIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes. Nat Methods 8(9): 737


P{CaryP} Strains

Site name BDSC# Genotype Estimated CytoSite# Transformant Eye Color1 Transformation Score [Avg. (BACs)]2
attP18 32107 y1 w67c23 P{CaryP}attP18 6C12 Orange 4.0 (0.0)
attP4 - y1 w67c23 P{CaryP}attP4 12C6 Orange 2.5 (0.0)
attP3 32230 y1 w* P{CaryP}attP3 19C4 Light Orange 0.9 (0.7)
attP40 - y1 w67c23; P{CaryP}attP40 25C6 Red 7.2 (3.7)
attP30 - y1 w67c23; P{CaryP}attP30 29C3 Red 4.0 (nd)
attP14 - y1 w67c23; P{CaryP}attP14 36A10 Orange 2.7 (1.0)
attP1 8621 y1 w67c23; P{CaryP}attP1 55C4 Red 6.4 (2.2)
attP23 - y1 w67c23; P{CaryP}attP23 60C7 Red - (nd)
attP88 - y1 w67c23; P{CaryP}attP88 64A12 Red 4.4 (nd)
attP2 8622 y1 w67c23; P{CaryP}attP2 68A4 Red 5.8 (1.9)
attP112 - y1 w67c23; P{CaryP}attP112 68C13 Red 3.0 (nd)
attP64 - y1 w67c23; P{CaryP}attP64 89B9 Red 5.3 (nd)
attP154 - y1 w67c23; P{CaryP}attP154 97D2 Orange 6.3 (1.8)
attPY 41124 y1 w*/Dp(2;Y)G; P{CaryP}attPY Y Red 4.3 (nd)
# FlyBase Drosophila melanogaster (R6.42)

1Eye color was determined three days after eclosion (heterozygous state)

2Transformation efficiency score was calculated based on our previous actual running orders. Average score and >30 kb BACs score were shown



PhiC31-RMCE Strains

Site name
Reference BDSC Stock#
Genotype
Estimated CytoSite#
Strain Eye Color3
Transformation Score 2
JB37B
P{attP.w[+].attP}JB37B
37B7
Red
6.8
JB38F
P{attP.w[+].attP}JB38F
38F1
Orange
6.4
JB53F
P{attP.w[+].attP}JB53F
53F8
Orange
3.8
JB53F
P{attP.w[+].attP}tara[JB89B]
89B8
Red
5.8
38451
w1118; Dr1/TM3, P{attP.w+.attP}FS10Sb1 Ser1
79A2
Orange
3.3
38452
w1118; Dr1/TM3, Sb1 Ser1 P{attP.w+.attP}FS18
100D1
Orange
2.0
38453
y1 w*; snaSco/CyO, P{attP.w+.attP}J04
37B8
Orange
9.0
38454
y1 w*; snaSco/CyO, P{attP.w+.attP}J08
37F2
Red
4.6
38455
FM7h, P{attP.w+.attP}FS2/C(1)DX, y1 f1
10B6
Red
4.6
38456
FM7h, P{attP.w+.attP}FS5/C(1)DX, y1 f1
6F3
Orange
3.0

# FlyBase Drosophila melanogaster (R6.42)
2Transformation efficiency score was calculated based on our previous actual running orders. Average score and >30 kb BAC scores were shown
3Eye color was determined three days after eclosion. This is the color of the original stock, not the transformant


P[acman] Strains 

Site name
BDSC Stock#
Genotype
Estimated CytoSite#
Transformant Eye Color1
Transformation Score [Avg. (BACs)]2
VK10
97294
PBac{yellow[+]-attP-3B}VK00010
chromosome2
-
- (nd)
VK15
PBac{yellow[+]-attP-9A}VK00015
chromosome2
Red
3.3 (2.4)
VK38
PBac{yellow[+]-attP-3B}VK00038
5B8
Red
4.1 (0.8)
VK06
PBac{yellow[+]-attP-9A}VK00006
19E7
Light Orange
1.9 (1.3)
VK37
PBac{yellow[+]-attP-3B}VK00037
22A3
Orange
5.8 (2.4)
VK12
PBac{yellow[+]-attP-9A}VK00012
25A3
Light Orange
0.5 (nd)
VK02
PBac{yellow[+]-attP-3B}VK00002
28E7
Red
6.4 (2.7)
VK11
PBac{yellow[+]-attP-3B}VK00011
40E4
Red
0.5 (0.0)
VK14
PBac{yellow[+]-attP-9A}VK00014
43A1
Orange
6.4 (2.7)
VK16
PBac{yellow[+]-attP-3B}VK00016
47C6
Orange
5.0 (3.2)
VK30
9747
PBac{yellow[+]-attP-9A}VK00030
50E1
Orange
3.7 (1.4)
VK18
PBac{yellow[+]-attP-9A}VK00018
53B2

Orange

(maybe variegated)

6.6 (2.6)
VK22
PBac{yellow[+]-attP-9A}VK00022
57F5
Orange
6.9 (2.9)
VK01
PBac{yellow[+]-attP-3B}VK00001
59D3
Orange
4.8 (3.8)
VK31
PBac{yellow[+]-attP-3B}VK00031
62E1
Orange
6.3 (2.8)
VK33
PBac{yellow[+]-attP-3B}VK00033
65B2
Red
6.2 (3.5)
VK39
PBac{yellow[+]-attP-3B}VK00039
67E4
-
4.8 (nd)
VK19
PBac{yellow[+]-attP-9A}VK00019
68D2
Red
4.2 (1.9)
VK23
PBac{yellow[+]-attP-9A}VK00023
70A2
Red
4.7 (3.8)
VK36
PBac{yellow[+]-attP-3B}VK00036
70C4
Red
4.0 (nd)
VK05
PBac{yellow[+]-attP-9A}VK00005
75A10
Orange
7.2 (2.2)
VK13
PBac{yellow[+]-attP-9A}VK00013
76A2
Red
6.0 (4.4)
VK21
PBac{yellow[+]-attP-9A}VK00021
76C5
Orange
- (nd)
VK07
PBac{yellow[+]-attP-3B}VK00007
82A1
Orange
2.7 (0.0)
VK32
PBac{yellow[+]-attP-3B}VK00032
85A2
Light Orange
1.4 (0.0)
VK40
PBac{yellow[+]-attP-3B}VK00040
87B10
Red
7.2 (1.4)
VK27
PBac{yellow[+]-attP-9A}VK00027
89E11
Red
7.6 (1.8)
VK28
PBac{yellow[+]-attP-9A}VK00028
92F1
Orange
6.8 (1.5)
VK26
PBac{yellow[+]-attP-9A}VK00026
96F3
Light Orange
2.7 (3.8)
VK20
PBac{yellow[+]-attP-9A}VK00020
99F8
Light Orange
4.8 (3.6)
VK24
97424
PBac{yellow[+]-attP-9A}VK00024
101F1
-
0.0 (nd)

# FlyBase Drosophila melanogaster (R6.42)
1Eye color was determined three days after eclosion (heterozygous state)
2Transformation efficiency score was calculated based on our previous actual running orders. Average score and >30 kb BACs score were shown
4This line was very hard to transform


FlyC31 Strains

Site name
Reference BDSC Stock#
Genotype
Estimated CytoSite#
Transformant Eye Color1
Transformation Score [Avg. (BACs)]2
ZH-2A
M{3xP3-RFP.attP'}ZH-2A
2A3
Orange
3.3 (0.6)
ZH-22A
M{3xP3-RFP.attP'}ZH-22A
22A2
Light Orange
5.2 (3.4)
ZH-51C
M{3xP3-RFP.attP'}ZH-51C
51C1
Light Orange
7.5 (4.9)
ZH-51D
M{3xP3-RFP.attP}ZH-51D
51D9
Red
6.2 (2.4)
ZH-58A
M{3xP3-RFP.attP}ZH-58A
58A3
Light Orange
7.0 (5.5)
ZH-68E
M{3xP3-RFP.attP'}ZH-68E
68E1
Light Orange
6.8 (2.9)
ZH-86Fa
M{3xP3-RFP.attP'}ZH-86Fa
86E18
Red
7.0 (3.8)
ZH-86Fb
M{3xP3-RFP.attP}ZH-86Fb
86F8
Red
7.3 (4.3)
ZH-102D
M{3xP3-RFP.attP}ZH-102D (with M{vas-int.Dm}ZH-2A)
102F4
Red
7.3 (4.0)
24480NF
-
24480NF6 ZH-2A
2A3
Orange
2.0 (nd)
24481NF
-
24481NF7 ZH-22A
22A2
Light Orange
- (0.0)
24482NF
-
24482NF7 ZH-51C
51C1
Orange
2.0 (nd)
24483NF
-
24483NF7 ZH-51D
51D9
Red
3.4 (nd)
24484NF
-
24484NF7 ZH-58A
58A3
Light Orange
1.3 (nd)
24485NF
-
24485NF7 ZH-68E
68E1
Light Orange
1.1 (0.0)
24486NF
-
24486NF7 ZH-86Fa
86E18
Red
5.9 (nd)
24749NF
-
24749NF7 ZH-86Fb
86F8
Red
8.3 (2.4)

# FlyBase Drosophila melanogaster (R6.42)
1Eye color was determined three days after eclosion (heterozygous state)
2Transformation efficiency score was calculated based on our previous actual running orders. Average score and >30 kb BACs score were shown

5Enhancer trap effect from a nearby gene hibris and is not useful for reporter gene analysis and other applications where ectopic expression is an issue

6M{vas-int.Dm}ZH-102D removed and loxP-3xP3-RFP removed version

7M{vas-int.Dm}ZH-2A removed and loxP-3xP3-RFP removed version

8Plan I is NOT available for this stock


Other Strains

Site name
BDSC Stock#
Genotype
Estimated CytoSite#
Transformant Eye Color1
Transformation Score [Avg. (BACs)]2
su(Hw)attP8
y1 w* P{CaryIP}su(Hw)attP8
8E10
Red
3.8 (0.0)
su(Hw)attP6
y1 w* P{CaryIP}su(Hw)attP6
24A2
Red
2.0 (nd)
su(Hw)attP5
y1 w* P{CaryIP}su(Hw)attP5
50F1
Red
6.2 (5.0)
su(Hw)attP4
y1 w* P{CaryIP}su(Hw)attP4
67E2
Red
2.0 (nd)
su(Hw)attP2
y1 w* P{CaryIP}su(Hw)attP2
92D9 Red 4.8 (nd)
-
3476910
y1 P{CaryIP}su(Hw)attP8 v1
8E10
-
6.0 (nd)
VIE260B
P{attP,y+,w3'}VIE-260B
40D3
Red
8.5 (nd)
JK22C aka JMK-96
-
w1118; P{CaryP}JK22C
22C3
Red
5.9 (0.0)
JK65C aka JMK-98
-
w1118; P{CaryP}JK65C
65C3
Red
5.5 (0.0)
JK66B aka JMK-99
-
w1118; P{CaryP}JK66B
66B4
Red
3.8 (1.2)

# FlyBase Drosophila melanogaster (R6.42)
1Eye color was determined three days after eclosion (heterozygous state)
2Transformation efficiency score was calculated based on our previous actual running orders. Average score and >30 kb BACs score were shown
9This strain has very high non-specific integration rate. Service W (PCR confirmation of integration site) is highly recommended

10This strain is suitable to screen for vermilion+ on X chromosome attP site